Top News: Bellicum Pharmaceuticals (NASDAQ:BLCM), Acasti Pharma Inc. (NASDAQ:ACST), First Financial Corp. (NASDAQ:THFF), Johnson & Johnson (NYSE:JNJ), International Business Machines (NYSE:IBM)

On Friday shares of Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) closed at $23.02. Bellicum Pharma (NASDAQ:BLCM) announced that clinical results from a study conducted by the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children’s Hospital, and Houston Methodist using the Company’s Caspase-9 safety switch (CaspaCIDe), were simultaneously published in BLOOD and featured today in a late-breaking oral presentation of the American Society of Gene and Cell Therapy (ASGCT) 18th Annual Meeting in New Orleans.

Acasti Pharma Inc. (NASDAQ:ACST) in last trading activity advanced 0.61% to close at $0.38. Company weekly performance is -6.76% while its quarterly performance stands at -13.11%. Acasti Pharma Inc. (NASDAQ:ACST) is -68.66% away from its 52 week high. It was reported on 11 May, that Acasti Pharma Inc. (NASDAQ:ACST) has now been given an additional 180 calendar days, until November 2, 2015, to regain compliance with the minimum $1.00 per share requirement for continued listing on the NASDAQ.

On last trading day First Financial Corp. (NASDAQ:THFF) decreased -0.71% to close at $33.78. Its volatility for the week is 1.85% while volatility for the month is 1.78%. THFF’s sales growth for past 5 years was -2.10% and its EPS growth for past 5 years was 8.10%. First Financial Corp. (NASDAQ:THFF) monthly performance is -3.90%. Zacks upgraded shares of First Financial Corp (NASDAQ:THFF) from a sell rating to a hold rating in a research note released on 11 May.

On Friday shares of Johnson & Johnson (NYSE:JNJ) closed at $102.30. Company’s sales growth for last 5 years was 3.70% and EPS growth for next 5 years is recorded as 5.13%. Johnson & Johnson (NYSE:JNJ) and Actavis plc (NYSE:ACT) have been cleared of any wrongdoing after being accused of not doing enough to warn patients of addiction risks posed by their prescription pain killers on sale. However, Purdue Pharma will have to make its case after a U.S District Court concluded it had a case to answer on the same issue.

International Business Machines Corporation (NYSE:IBM) in last trading activity fell -0.45% to close at $173.26. Company weekly performance is 0.34% while its quarterly performance stands at 8.83%. International Business Machines Corporation (NYSE:IBM) is -9.35% away from its 52 week high. International Business Machines Corporation (NYSE:IBM) has announced new servers, and storage software and solutions that it said would help more clients create hybrid cloud computing environments.

News Buzz: CSI Compressco LP (NASDAQ:CCLP), Acasti Pharma Inc. (NASDAQ:ACST), CHC Group (NYSE:HELI), Hewlett-Packard Company (NYSE:HPQ), XPO Logistics (NYSE:XPO)

On Thursday shares of CSI Compressco LP (NASDAQ:CCLP) closed at $20.18. Company’s sales growth for last 5 years was 25.50%. CSI Compressco LP (NASDAQ:CCLP) announced first quarter 2015 consolidated results. Adjusted earnings before interest, taxes, depreciation, and amortization (Adjusted EBITDA) for the first quarter of 2015 were $31.2 million, with net income of $1.8 million. This compares to Adjusted EBITDA and net income of $9.3 million and $4.6 million, respectively, during the prior year period.

Acasti Pharma Inc. (NASDAQ:ACST) in last trading activity increased 2.17% to close at $0.42. Company weekly performance is 4.73% while its quarterly performance stands at -2.58%. Acasti Pharma Inc. (NASDAQ:ACST) is -65.66% away from its 52 week high. On April 29, Acasti Pharma Inc. (NASDAQ:ACST), announces the departure of André Godin as Chief Financial Officer of Acasti effective immediately.

On last trading day CHC Group Ltd. (NYSE:HELI) remains unchanged to close at $1.40. Its volatility for the week is 8.00% while volatility for the month is 8.39%. HELI’s sales growth for past 5 years was 18.30% and its EPS growth for past 5 years was 32.10%. CHC Group Ltd. (NYSE:HELI) monthly performance is 15.70%. Zacks downgraded shares of CHC Group (NASDAQ:HELI) from a hold rating to a sell rating in a report issued on Monday.

Hewlett-Packard Company (NYSE:HPQ) has 0.10% insider ownership while its institutional ownership stands at 79.30%. In last trading activity company’s stock closed at $32.82. On May 05, new details of Hewlett-Packard Company (NYSE:HPQ)’s $5.1bn (£3.6bn) lawsuit against Autonomy have emerged in a court filing. In the documents, HP accused two former Autonomy executives of artificially inflating the company’s revenue before HP bought the firm.

On last trading day XPO Logistics, Inc. (NYSE:XPO) increased 1.77% to close at $49.00. Its volatility for the week is 3.54% while volatility for the month is 3.42%. XPO’s sales growth for past 5 years was 88.10% and its EPS growth for past 5 years was -63.00%. XPO Logistics, Inc. (NYSE:XPO) monthly performance is 13.27%. On May 04, XPO Logistics, Inc. (NYSE:XPO) announced its second acquisition in a week on Monday, saying it will buy port trucking provider Bridge Terminal Transport Services Inc. The $100 million acquisition will give the Greenwich, Conn.-based XPO greater ability to handle shipments at U.S. gateways and potentially align some of its logistics and transport services with business the company is gaining through its recently announced purchase of French contract-logistics firm Norbert Dentressangle SA .

Active Stocks: Acasti Pharma Inc. (NASDAQ:ACST), ReachLocal (NASDAQ:RLOC), Facebook Inc (NASDAQ:FB), General Electric (NYSE:GE), E. I. du Pont de Nemours (NYSE:DD)

Acasti Pharma Inc. (NASDAQ:ACST) in last trading activity increased 7.67% to close at $0.42. Company weekly performance is -6.69% while its quarterly performance stands at -6.69%. Acasti Pharma Inc. (NASDAQ:ACST) is -65.58% away from its 52 week high. On April 29, Acasti Pharma Inc. (NASDAQ:ACST), announces the departure of André Godin as Chief Financial Officer of Acasti effective immediately. The Corporation would like to thank André for his leadership and service over the years and wishes him all the best in his future endeavours.

On last trading day ReachLocal, Inc. (NASDAQ:RLOC) remains unchanged to close at $2.87. Its volatility for the week is 3.19% while volatility for the month is 4.08%. RLOC’s sales growth for past 5 years was 18.50%. ReachLocal, Inc. (NASDAQ:RLOC) monthly performance is -2.71%. On April 22, ReachLocal Inc. (NASDAQ:RLOC), is now making its ReachEdge lead conversion and marketing automation software available for use with websites developed on other platforms. Addressing the top requested functionality in small business marketing automation software, ReachEdge software, the foundation of ReachLocal’s total digital marketing system, is the only solution that lets local businesses track leads from all their marketing sources, capture and nurture leads, convert leads through automatic reminders, and understand all the data needed to get the most from their online marketing.

On Monday shares of Facebook Inc (NASDAQ:FB) closed at $78.81. Company’s sales growth for last 5 years was 74.20% and EPS growth for next 5 years is recorded as 27.28%. David Goldberg, husband of Facebook Inc.’s (NASDAQ:FB) chief operating officer Sheryl Sandberg, died suddenly on Friday after falling from a treadmill at a gym at the Four Seasons Hotel in Punta Mita, Mexico, according to reports citing a spokeswoman for the attorney general’s office of Nayarit state. Goldberg, chief executive officer of SurveyMonkey.com, was 47-years-old.

General Electric Company (NYSE:GE) in last trading activity moved down -0.15% to close at $27.27. Company weekly performance is 1.45% while its quarterly performance stands at 13.67%. General Electric Company (NYSE:GE) is -4.92% away from its 52 week high. General Electric Company (NYSE:GE)’s CEO will meet Europe’s antitrust chief on Tuesday, according to a source, in what is expected to be a push for unconditional EU approval for its 12.4-billion-euro ($13.8 billion) bid for an Alstom business.

On last trading day E. I. du Pont de Nemours and Company (NYSE:DD) moved down -0.01% to close at $74.03. Its volatility for the week is 1.21% while volatility for the month is 1.62%. DD’s sales growth for past 5 years was 5.10% and its EPS growth for past 5 years was 15.30%. E. I. du Pont de Nemours and Company (NYSE:DD) monthly performance is 3.70%. E. I. du Pont de Nemours and Company (NYSE:DD) settled a long-running trade-secrets case against rival Kolon Industries Inc. involving fiber used to manufacture bulletproof vests. Kolon agreed to pay DuPont $275 million in restitution as part of a settlement that included upfront and ongoing payments, officials for the companies said Thursday.

Stay on: Whiting Petroleum Corp. (NYSE:WLL), The Bank of New York Mellon (NYSE:BK), UFP Technologies (NASDAQ:UFPT), Acasti Pharma (NASDAQ:ACST), Vodafone Group (NASDAQ:VOD)

Whiting Petroleum Corp. (NYSE:WLL) has received buyout interest from Exxon Mobil Corp., Continental Resources Inc. and Hess Corp, Bloomberg TV reported Friday. The Wall Street Journal reported last week that Whiting is seeking a buyer after plummeting crude prices hurt the oil- and-gas producer’s results and its shares tumbled. On Friday shares of Whiting Petroleum Corp. (NYSE:WLL) closed at $40.00. Company’s sales growth for last 5 years was 26.90% and EPS growth for next 5 years is recorded as -11.17%.

The Bank of New York Mellon Corporation (NYSE:BK)’s embattled CEO Gerald Hassell got a 23 percent bump in total compensation in 2014, taking home $11.7 million during a year in which bank management came under fire from Wall Street for not doing enough to boost revenue and cut costs. Hassell’s base compensation, disclosed in a regulatory filing late Friday, stayed the same at $1 million as in 2013, when he earned total compensation of $9.5 million. The Bank of New York Mellon Corporation (NYSE:BK) in last trading activity advanced 1.24% to close at $40.94. Company weekly performance is 4.23% while its quarterly performance stands at 0.86%. The Bank of New York Mellon Corporation (NYSE:BK) is -1.58% away from its 52 week high.

On March 4, Ufp Technologies, Inc. (NASDAQ:UFPT) reported a 53.48 percent plunge in profit for the quarter ended Dec. 31, 2014. The company has earned $1.57 million, or $0.22 a share in the quarter, compared with $3.38 million, or $0.47 a share for the same period last year. On last trading day UFP Technologies, Inc. (NASDAQ:UFPT) decreased -2.87% to close at $20.32. Its volatility for the week is 5.73% while volatility for the month is 3.69%. UFPT’s sales growth for past 5 years was 7.00% and its EPS growth for past 5 years was 2.20%. UFP Technologies, Inc. (NASDAQ:UFPT) monthly performance is -11.81%.

On March 2, Acasti Pharma Inc. (NASDAQ:ACST), announced that it has received full data for its Phase II double blind, placebo controlled (TRIFECTA) trial. Acasti Pharma Inc. (NASDAQ:ACST) in last trading activity company’s stock closed at $0.51.

Stifel Nicolaus reiterated their sell rating on shares ofVodafone Group Plc (ADR) (NASDAQ:VOD) in a research note released on Friday morning. They currently have a GBX 195 ($2.94) target price on the stock. On Friday shares of Vodafone Group Plc (ADR) (NASDAQ:VOD) closed at $32.37. Company’s sales growth for last 5 years was -1.30%.

Top Stocks: Codexis (NASDAQ:CDXS), Advanced Micro Devices (NASDAQ:AMD), Intrexon Corporation (NYSE:XON), Acasti Pharma Inc. (NASDAQ:ACST), American National Insurance Co. (NASDAQ:ANAT)

Zacks cut shares of Codexis, Inc. (NASDAQ:CDXS) to a neutral rating in a research report sent to investors on Friday morning. The firm currently has $3.10 price target on the stock. On Monday shares of Codexis, Inc. (NASDAQ:CDXS) closed at $3.11. Company’s sales growth for last 5 years was -8.80% and EPS growth for next 5 years is recorded as 15.00%.

On 19 January, Advanced Micro Devices, Inc. (NASDAQ:AMD) posted revenue of $1.24 billion in the period, matching Street forecasts. Advanced Micro Devices, Inc. (NASDAQ:AMD) in last trading activity advanced 6.53% to close at $2.61. Company weekly performance is 9.21% while its quarterly performance stands at -2.97%. Advanced Micro Devices, Inc. (NASDAQ:AMD) is -45.63% away from its 52 week high.

Intrexon Corporation (NYSE:XON) announced it has launched a tender offer to acquire the remaining stake in Exemplar Genetics, a company committed to enabling the study of life-threatening human diseases. Utilizing its proprietary technologies in animal genetics, Exemplar has developed a broad pipeline of transgenic swine models for research and development of heart disease, cancer, cystic fibrosis, cardiac arrhythmia, neuromuscular and neurodegenerative disorders. ExeGen LDLR-/-&+/- is the Company’s most advanced porcine model designed to empower superior drug and device discovery in the area of cardiac disease. On Monday shares of Intrexon Corporation (NYSE:XON) closed at $29.36.

On 13 January, Acasti Pharma Inc. (NASDAQ:ACST) announced its results for the three and nine-months ended November 30, 2014. Revenues were $29,000 for the third quarter ended November 30, 2014, versus $28,000 for the quarter ended November 30, 2013. Acasti Pharma Inc. (NASDAQ:ACST)‘s stock closed at $0.49.

On 12 January, American National Insurance Co. (NASDAQ:ANAT) said that it will use BillingCenter to manage its billing and payment operations across all P&C lines of business. On last trading day American National Insurance Co. (NASDAQ:ANAT) advanced 1.52% to close at $107.10. Its volatility for the week is 2.70% while volatility for the month is 2.67%. ANAT’s sales growth for past 5 years was 1.70% and its EPS growth for past 5 years was 28.60%. American National Insurance Co. (NASDAQ:ANAT) monthly performance is -6.71%.

Stocks Buzz: Sirius XM Holdings Inc. (NASDAQ:SIRI), Plug Power Inc. (NASDAQ:PLUG), Sibanye Gold Limited (NYSE:SBGL), Acasti Pharma Inc. (NASDAQ:ACST), Multi-Fineline Electronix (NASDAQ:MFLX)

On 15 January Sirius XM Holdings Inc. (NASDAQ:SIRI) announced the selection procedure to lease one Qualified Entity channel to be broadcast via satellite and available online. On Thursday shares of Sirius XM Holdings Inc. (NASDAQ:SIRI) closed at $3.61. Company’s sales growth for last 5 years was 18.00% and EPS growth for next 5 years is recorded as 17.20%.

Plug Power Inc. (NASDAQ:PLUG) announced it will host its January Business Update conference call and webcast on January 28, 2015. On this call CEO, Andy Marsh and CFO, Paul Middleton will provide a general business status update. Plug Power Inc. (NASDAQ:PLUG) in last trading activity moved up 8.21% to close at $2.90. Company weekly performance is 5.45% while its quarterly performance stands at -34.24%. Plug Power Inc. (NASDAQ:PLUG) is -75.26% away from its 52 week high.

CIBC downgraded shares of Sibanye Gold Limited (NYSE:SBGL) from an outperform rating to a sector perform rating in a report issued on Tuesday. On last trading day Sibanye Gold Limited (NYSE:SBGL) fell -1.62% to close at $10.93. Its volatility for the week is 4.57% while volatility for the month is 5.65%. SBGL’s sales growth for past 5 years was 4.30% and its EPS growth for past 5 years was -3.90%. Sibanye Gold Limited (NYSE:SBGL) monthly performance is 37.48%.

On 13 January Acasti Pharma Inc. (NASDAQ:ACST) announced its results for the three and nine-months ended November 30, 2014. Revenues were $29,000 for the third quarter ended November 30, 2014, versus $28,000 for the quarter ended November 30, 2013. Net earnings were $3,012,000 for the quarter, versus a net loss of $(3,856,000) in the prior year. Acasti Pharma Inc. (NASDAQ:ACST) ‘s stock closed at $0.46.

On 13 January Multi-Fineline Electronix, Inc. (NASDAQ:MFLX) reported preliminary financial results for the calendar fourth quarter ended December 31, 2014. The Company expects net sales in the fourth quarter of calendar 2014 to be at the high end of the Company’s guidance range at approximately $209 million, compared to net sales of $211.7 million in the same quarter last year. Multi-Fineline Electronix, Inc. (NASDAQ:MFLX) has 1.20% insider ownership while its institutional ownership stands at 33.10%. In last trading activity company’s stock closed at $12.13.

Market Watch List: General Electric Company (NYSE:GE), Staples (NASDAQ:SPLS), Paramount Gold and Silver Corp. (NYSEMKT:PZG), HSBC Holdings (NYSE:HSBC), Acasti Pharma (NASDAQ:ACST)

General Electric Company (NYSE:GE) announced a 5% hike in its dividend payout to a quarterly payment of 23 cents per share or 92 cents on an annualized basis. The current dividend hike is the seventh of its kind in the last five years. The increased dividend is payable on Jan 26, 2015 to shareholders of record as of Dec 18, 2014. General Electric Company (NYSE:GE) in last trading activity moved down -0.41% to close at $24.49. Company weekly performance is -4.26% while its quarterly performance stands at -5.99%. General Electric Company (NYSE:GE) is -10.58% away from its 52 week high.

Staples, Inc. (NASDAQ:SPLS) has awarded $5,000 to Nebraska Sports Council under a program that lets Staples associates direct donations. The Staples associate who directed the funds, Dan Brockhaus, volunteers with the organization. On last trading day Staples, Inc. (NASDAQ:SPLS) moved up 2.31% to close at $17.25. Its volatility for the week is 4.40% while volatility for the month is 3.36%. SPLS’s sales growth for past 5 years was 0.00% and its EPS growth for past 5 years was -1.10%. Staples, Inc. (NASDAQ:SPLS) monthly performance is 28.25%.

On 10 December Paramount Gold and Silver Corp. (NYSEMKT:PZG) reported drill results for three additional holes from its San Miguel project in Mexico. The company stated that exceptional results from the three infill holes “are likely to upgrade resources to the measured and indicated categories and potentially increase the resource size and grade.” On last trading day Paramount Gold and Silver Corp. (NYSEMKT:PZG) moved down -8.54% to close at $0.64. Its volatility for the week is 10.04% while volatility for the month is 9.50%. PZG’s EPS growth for past 5 years was 10.20%. Paramount Gold and Silver Corp. (NYSEMKT:PZG) monthly performance is -4.43%.

HSBC Holdings plc (ADR) (NYSE:HSBC)‘s stock had its “hold” rating reiterated by research analysts at Shore Capital in a report released on Tuesday. HSBC Holdings plc (ADR) (NYSE:HSBC) has institutional ownership stands at 3.10%. In last trading activity company’s stock closed at $46.91.

Acasti Pharma Inc. (NASDAQ:ACST) announced the grant of an aggregate of 180,000 incentive stock options under the Corporation’s Stock Option Plan for its senior executive and management team. Each option will vest gradually over a period of two years and will entitle its holder to purchase one common share of Acasti at a price of CDN $0.65 until October 19, 2019. On Tuesday shares of Acasti Pharma Inc. (NASDAQ:ACST) closed at $0.54.

Momentum Stocks: Maxwell Technologies (NASDAQ:MXWL), CBS Corporation (NYSE:CBS), Dejour Energy Inc. (NYSEMKT:DEJ), Acasti Pharma Inc. (NASDAQ:ACST), Stock Building Supply Holdings (NASDAQ:STCK)

Maxwell Technologies, Inc. (NASDAQ:MXWL) announced on 6 November that it has been awarded a $2.68 million cost-shared technology development contract by the United States Advanced Battery Consortium LLC (USABC) to develop a high-performance hybrid ultracapacitor/lithium-ion battery for stop-start idle-elimination microhybrid autos. Maxwell Technologies, Inc. (NASDAQ:MXWL) in last trading activity decreased -7.38% to close at $10.41. Company weekly performance is -4.67% while its quarterly performance stands at 10.74%. Maxwell Technologies, Inc. (NASDAQ:MXWL) is -43.52% away from its 52 week high.

CBS Corporation (NYSE:CBS) announced that Leslie Moonves, President and Chief Executive Officer, will participate in a question-and-answer session at the UBS 42nd Annual Global Media and Communications Conference in New York on Tuesday, December 9, 2014. On last trading day CBS Corporation (NYSE:CBS) increased 1.52% to close at $53.34. Its volatility for the week is 1.94% while volatility for the month is 2.11%. CBS’s sales growth for past 5 years was 1.80% and its EPS growth for past 5 years was 16.80%. CBS Corporation (NYSE:CBS) monthly performance is -1.66%.

Dejour Energy Inc. (NYSEMKT:DEJ) an independent oil and gas exploration and production company operating in North America’s Piceance Basin and Peace River Arch regions, announced its financial results for the three and nine month periods ended September 30, 2014. Increased production by 7% to 496 BOE/d for the nine months ended September 30, 2014 from production of 465 BOE/d for the comparative period in 2013; Increased gross revenues by 10% from $7.0 million for the nine months ended September 30, 2013 to $7.6 million for the nine months ended September 30, 2014. On last trading day Dejour Energy Inc. (NYSEMKT:DEJ) decreased -1.41% to close at $0.23. Its volatility for the week is 10.63% while volatility for the month is 7.54%. DEJ’s sales growth for past 5 years was 5.30% and its EPS growth for past 5 years was 45.60%. Dejour Energy Inc. (NYSEMKT:DEJ) monthly performance is -4.17%.

TheStreet lowered shares of Stock Building Supply Holdings (NASDAQ:STCK) from a hold rating to a sell rating in a research report released on Wednesday morning. Acasti Pharma Inc. (NASDAQ:ACST) stock closed at $0.43.

Acasti Pharma Inc. (NASDAQ:ACST) an emerging biopharmaceutical company focused on the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment and prevention of certain cardiometabolic disorders, announced that on November 7, 2014 it received notification from the NASDAQ Listing Qualifications Department for failing to maintain a minimum bid price of US$1.00 per share for the last 30 consecutive business days, as required by NASDAQ Listing Rule 5550(a)(2) – bid price. On Wednesday shares of Stock Building Supply Holdings, Inc. (NASDAQ:STCK) closed at $15.20. Company’s EPS growth for next 5 years is recorded as 76.00%.

Why these Biotech stocks Declined: Acasti Pharma Inc. (NASDAQ:ACST), Recro Pharma (NASDAQ:REPH), Compugen (NASDAQ:CGEN), ContraFect Corporation (NASDAQ:CFRX), OXiGENE (NASDAQ:OXGN)

Acasti Pharma Inc. (NASDAQ:ACST) an emerging biopharmaceutical company focused on the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment and prevention of certain cardiometabolic disorders, announces that on November 7, 2014 it received notification from the NASDAQ Listing Qualifications Department for failing to maintain a minimum bid price of US$1.00 per share for the last 30 consecutive business days, as required by NASDAQ Listing Rule 5550(a)(2) — bid price. Acasti Pharma Inc. (NASDAQ:ACST) in last trading activity decreased -10.85% to close at $0.41. Company weekly performance is -16.31% while its quarterly performance stands at -57.28%. Acasti Pharma Inc. (NASDAQ:ACST) is -99.40% away from its 52 week high.

For the three months ended September 30, 2014, Recro Pharma Inc. (NASDAQ:REPH) on 10 November reported a net loss applicable to common shareholders of $4.7 million, or $0.61 per share, compared to a net loss applicable to common shareholders of $0.6 million, or $3.95 per share, for the comparable period in 2013. The third quarter of 2013 includes accretion of Recro Pharma’s redeemable convertible preferred stock. On last trading day Recro Pharma, Inc. (NASDAQ:REPH) decreased -1.47% to close at $2.69. Its volatility for the week is 5.46% while volatility for the month is 4.65%. Recro Pharma, Inc. (NASDAQ:REPH) monthly performance is -10.93%.

Compugen Ltd. (NASDAQ:CGEN) announced that Dr. Anat Cohen-Dayag President and Chief Executive Officer of Compugen will present a corporate overview and update at the Jefferies 2014 Global Healthcare Conference in London UK. The Compugen presentation is scheduled to start at 10:40 a.m. GMT on Thursday November 20 2014. On last trading day Compugen Ltd. (NASDAQ:CGEN) moved up 0.62% to close at $6.48. Its volatility for the week is 4.51% while volatility for the month is 4.40%. CGEN’s sales growth for past 5 years was 63.50% and its EPS growth for past 5 years was 3.90%. Compugen Ltd. (NASDAQ:CGEN) monthly performance is -15.84%.

For the three-month period ending Sept. 30, ContraFect Corporation (NASDAQ:CFRX) reported total unaudited assets of just more than $34 million, up from less than $10 million at the end of 2013. The company operated at a net loss for the third quarter of $16,397,678, a net loss per diluted share of common stock of $1.22. ContraFect has a net loss of $25,412,413 for the calendar year, which does not include a roughly $4.5 million dividend to its preferred stockholders. Overall, the company has a net loss per share of common stock of $5.76 for 2014. ContraFect Corporation (NASDAQ:CFRX) has 5.70% insider ownership while its institutional ownership stands at 0.90%. In last trading activity company’s stock closed at $2.80.

OXiGENE Inc., (NASDAQ:OXGN) a biopharmaceutical company developing novel cancer therapeutics, announced in a press release that the company has been granted a patent by the European Patent Office related to its current clinical product candidate, OXi4503. The patent (EP 2219451 B1) is drawn to the use of OXi4503 in treating non-solid myeloid neoplasm, including acute myeloid leukemia (AML). On Tuesday shares of OXiGENE, Inc. (NASDAQ:OXGN) closed at $1.78.

Investors Watch List: Acasti Pharma Inc. (NASDAQ:ACST), Kinder Morgan (NYSE:KMI), Stewart Information Services Corporation (NYSE:STC), JD.com (NASDAQ:JD), Pingtan Marine Enterprise (NASDAQ:PME)

On Nov. 11, Acasti Pharma Inc. (NASDAQ:ACST) announces that on November 7, 2014 it received notification from the NASDAQ Listing Qualifications Department for failing to maintain a minimum bid price of US$1.00 per share for the last 30 consecutive business days, as required by NASDAQ Listing Rule 5550(a)(2) – bid price. Acasti Pharma Inc. (NASDAQ:ACST) in last trading activity decreased -10.85% to close at $0.41. Company weekly performance is -16.31% while its quarterly performance stands at -57.28%. Acasti Pharma Inc. (NASDAQ:ACST) is -99.40% away from its 52 week high.

On Nov 14, Kinder Morgan, Inc. (NYSE:KMI) announced that the deadline for Kinder Morgan Energy Partners, L.P. and El Paso Pipeline Partners, L.P. unitholders to elect the form of consideration they wish to receive in each of KMP’s and EPB’s pending mergers with KMI is 5:00 p.m. ET on Nov. 24, 2014. On last trading day Kinder Morgan, Inc. (NYSE:KMI) advanced 0.40% to close at $40.41. Its volatility for the week is 2.18% while volatility for the month is 2.02%. KMI’s sales growth for past 5 years was 3.10% and its EPS growth for past 5 years was 17.40%. Kinder Morgan, Inc. (NYSE:KMI) monthly performance is 8.78%.

On November 13, Fitch Ratings has affirmed Stewart Information Services Corporation’s (NYSE:STC) Issuer Default Rating (IDR) at ‘BBB’ and the Insurer Financial Strength (IFS) ratings of Stewart’s insurance subsidiaries at ‘A-‘. On last trading day Stewart Information Services Corporation (NYSE:STC) decreased -1.05% to close at $35.00. Its volatility for the week is 1.99% while volatility for the month is 2.59%. STC’s sales growth for past 5 years was 4.40% and its EPS growth for past 5 years was 17.00%. Stewart Information Services Corporation (NYSE:STC) monthly performance is 17.21%.

JD.com, Inc. (NASDAQ:JD), said on Monday its third-quarter revenue rose 61 percent, as its number of customer accounts more than doubled to 46.1 million people from a year ago.
JD, a distant rival to giant Alibaba Group Holding, said in a statement that revenue rose to $4.73 billion, or 29 billion yuan, in the three months ended September. This was up from 18.04 billion yuan, roughly $2.95 billion, in the same period a year earlier. JD.com, Inc. (NASDAQ:JD) has institutional ownership stands at 14.20%. In last trading activity company’s stock closed at $25.41.

An investigation on behalf of investors of Pingtan Marine Enterprise Ltd (NASDAQ:PME) shares over potential securities laws violations by Pingtan Marine Enterprise and certain of its directors and officers in connection certain financial statements was announced. On Tuesday shares of Pingtan Marine Enterprise Ltd. (NASDAQ:PME) closed at $1.30.